Owens & Minor/$OMI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Owens & Minor
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
Ticker
$OMI
Sector
Primary listing
NYSE
Employees
23,200
Headquarters
Website
Owens & Minor Metrics
BasicAdvanced
$416M
-
-$15.63
1.03
-
Price and volume
Market cap
$416M
Beta
1.03
52-week high
$15.84
52-week low
$4.56
Average daily volume
2.2M
Financial strength
Current ratio
0.859
Quick ratio
0.088
Long term debt to equity
-596.323
Total debt to equity
-732.617
Interest coverage (TTM)
2.02%
Profitability
EBITDA (TTM)
518.887
Gross margin (TTM)
20.89%
Net profit margin (TTM)
-11.18%
Operating margin (TTM)
2.68%
Effective tax rate (TTM)
-2.69%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
3.81%
Return on equity (TTM)
-148.42%
Valuation
Price to revenue (TTM)
0.039
Price to book
-1.48
Price to tangible book (TTM)
-0.24
Price to free cash flow (TTM)
-2.496
Free cash flow yield (TTM)
-40.06%
Free cash flow per share (TTM)
-2.159
Growth
Revenue change (TTM)
64.35%
Earnings per share change (TTM)
2,708.24%
3-year revenue growth (CAGR)
2.89%
10-year revenue growth (CAGR)
1.05%
3-year earnings per share growth (CAGR)
97.41%
10-year earnings per share growth (CAGR)
31.33%
What the Analysts think about Owens & Minor
Analyst ratings (Buy, Hold, Sell) for Owens & Minor stock.
Bulls say / Bears say
Patient Direct segment revenue increased 5.7% YoY to $673.9 million in Q1 2025, with operating margin growing 173 basis points to 8.92% and mid-teens EBITDA growth, showing effective strategy shift to higher-margin home-care services (Investing.com May 8, 2025 turn6search1).
Management reiterated its full-year 2025 guidance—expecting revenue of $10.85–$11.15 billion, adjusted EBITDA of $560–$590 million, and adjusted EPS of $1.60–$1.85—reflecting confidence in the company’s performance and sustained demand amid uncertain macro conditions (Investing.com May 8, 2025 turn6search1).
The Board approved a $100 million share buyback program on February 26, 2025, underscoring strong cash flow and management’s commitment to returning capital to shareholders, which could support the stock price and shareholder interests (SEC 10-Q Mar 31, 2025 turn9search1).
Products & Healthcare Services segment operating income dropped to $1.2 million in Q1 2025 from $11.5 million a year earlier, due to a $17 million decline in revenue and ongoing margin pressure in the core distribution business (SEC 10-Q turn3search5).
Owens & Minor mutually ended its $1.36 billion Rotech acquisition on June 5, 2025, paying an $80 million termination fee and reversing $1 billion of notes, highlighting regulatory and integration challenges that eliminate expected home-care growth synergies (Business Wire June 5 2025) turn2search3.
S&P Global Ratings changed OMI’s outlook to negative because leverage was at 4.4× in 2024 and is projected to exceed 5× in 2025, pointing to refinancing risk and the chance of ratings downgrades if the Products & Healthcare Services sale does not sufficiently lower debt (Reuters via Investing.com Mar 21, 2025 turn8search2).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
Owens & Minor Financial Performance
Revenues and expenses
Owens & Minor Earnings Performance
Company profitability
Owens & Minor News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Owens & Minor stock?
Owens & Minor (OMI) has a market cap of $416M as of September 18, 2025.
What is the P/E ratio for Owens & Minor stock?
The price to earnings (P/E) ratio for Owens & Minor (OMI) stock is 0 as of September 18, 2025.
Does Owens & Minor stock pay dividends?
No, Owens & Minor (OMI) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Owens & Minor dividend payment date?
Owens & Minor (OMI) stock does not pay dividends to its shareholders.
What is the beta indicator for Owens & Minor?
Owens & Minor (OMI) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.